Alkermes plc. Files 8-K on Executive and Board Changes
Ticker: ALKS · Form: 8-K · Filed: 2025-09-12T00:00:00.000Z
Sentiment: neutral
Topics: corporate-governance, executive-changes, board-changes
Related Tickers: ALKS
TL;DR
Alkermes 8-K filed: board/exec changes, comp plans, Reg FD, financials.
AI Summary
Alkermes plc. filed an 8-K on September 12, 2025, reporting on the departure of directors or certain officers, the election of directors, the appointment of certain officers, and compensatory arrangements. The filing also includes Regulation FD disclosures and financial statements and exhibits.
Why It Matters
Changes in directors and officers can signal shifts in company strategy or governance, potentially impacting investor confidence and future performance.
Risk Assessment
Risk Level: low — This filing is routine and reports on corporate governance and disclosures, not a material event like an acquisition or product failure.
Key Players & Entities
- Alkermes plc. (company) — Registrant
- September 12, 2025 (date) — Date of Report
FAQ
What specific officer positions were affected by the changes reported in this 8-K?
The filing indicates changes related to 'Departure of Directors or Certain Officers' and 'Appointment of Certain Officers', but the specific positions are not detailed in the provided excerpt.
Are there any new directors elected to the Alkermes plc. board?
Yes, the filing explicitly lists 'Election of Directors' as an item being reported.
What is the nature of the 'Compensatory Arrangements' mentioned?
The filing states 'Compensatory Arrangements of Certain Officers' are being reported, but the details of these arrangements are not provided in this excerpt.
Does this 8-K filing include any financial statements?
Yes, the filing explicitly lists 'Financial Statements and Exhibits' as part of the report.
What is the jurisdiction of incorporation for Alkermes plc.?
Alkermes plc. is incorporated in Ireland.
Filing Stats: 1,478 words · 6 min read · ~5 pages · Grade level 11.9 · Accepted 2025-09-12 09:09:56
Key Financial Figures
- $0.01 — on which registered Ordinary shares, $0.01 par value ALKS Nasdaq Global Select
- $615,000 — 's annual base salary will initially be $615,000 and he will be eligible to receive an a
- $3,500,000 — grant with an aggregate target value of $3,500,000, consisting of approximately 67% time-v
Filing Documents
- alks-20250912.htm (8-K) — 71KB
- alks-ex99_1.htm (EX-99.1) — 12KB
- 0001193125-25-201840.txt ( ) — 200KB
- alks-20250912.xsd (EX-101.SCH) — 30KB
- alks-20250912_htm.xml (XML) — 5KB
01 Regulation FD Disclosure
Item 7.01 Regulation FD Disclosure. On September 12, 2025, the Company issued a press release announcing Mr. Reed's appointment, a copy of which is furnished herewith as Exhibit 99.1 and is incorporated herein by reference. The information in this Item 7.01, and in Exhibit 99.1 furnished herewith, shall not be deemed "filed" for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), or otherwise subject to the liabilities of that section, nor incorporated by reference in any filing under the Securities Act of 1933, as amended, or the Exchange Act, except as shall be expressly set forth by specific reference in such a filing.
01 Financial Sta tements and Exhibits
Item 9.01 Financial Sta tements and Exhibits. (d) Exhibits EXHIBIT INDEX Exhibit No. Description 99.1 Press release issued by Alkermes plc dated September 12, 2025. 104 Cover page interactive data file (embedded within the Inline XBRL document). 3 SIGNA TURE Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. ALKERMES PLC Date: September 12, 2025 By: /s/ David J. Gaffin David J. Gaffin Secretary 4